First Flight Courier
⚠️ Moderate Risk
FEI: 3003304350 • Dubai • UNITED ARAB EMIRATES
FEI Number
3003304350
Location
Dubai
Country
UNITED ARAB EMIRATESAddress
P O Box 28859, , Dubai, , United Arab Emirates
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/1/2006 | 65GAJ99PIGMENTATION AGENT N.E.C. | New York District Office (NYK-DO) | |
| 12/12/2005 | 65VCA15DIAZEPAM (SEDATIVE) | New York District Office (NYK-DO) | |
| 6/16/2005 | 62SDK99ANTI-SEBORRHEIC N.E.C. | New York District Office (NYK-DO) | |
| 5/23/2005 | 66VBL99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 4/4/2005 | 66MDA03ALPRAZOLAM (TRANQUILIZER) | New York District Office (NYK-DO) | |
| 11/12/2004 | 62LDA40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 10/20/2004 | 56YDA99ANTIBIOTIC N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/10/2004 | 62OCA10TERAZOSIN HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II) | New York District Office (NYK-DO) | |
| 3/25/2004 | 60LCA47PENTAZOCINE (ANALGESIC) | New York District Office (NYK-DO) | |
| 2/27/2004 | 64BBA37SPIRONOLACTONE (DIURETIC) | New York District Office (NYK-DO) | |
| 2/27/2004 | 62KBC10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | New York District Office (NYK-DO) | |
| 2/27/2004 | 62VBA01AMANTADINE HCL (ANTI-VIRAL) | New York District Office (NYK-DO) |
Frequently Asked Questions
What is First Flight Courier's FDA import refusal history?
First Flight Courier (FEI: 3003304350) has 12 FDA import refusal record(s) in our database, spanning from 2/27/2004 to 12/1/2006.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. First Flight Courier's FEI number is 3003304350.
What types of violations has First Flight Courier received?
First Flight Courier has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about First Flight Courier come from?
All FDA import refusal data for First Flight Courier is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.